Results 101 to 110 of about 5,026 (202)

suPAR: The unspecific marker for disease presence, severity and prognosis

International Journal of Antimicrobial Agents, 2015
Investigation of biomarkers that can promptly predict unfavourable outcome of critically illness is an emerging necessity taking into consideration the need for early intervention, the shortage of available beds in intensive care units and the considerable cost of hospitalisation.
Eugen-Olsen, J., Giamarellos-Bourboulis, E.J.   +1 more
openaire   +3 more sources

Soluble urokinase plasminogen activator receptor (suPAR) is associated with metabolic changes in HIV-1 infected Africans: a prospective study

, 2012
Soluble urokinase plasminogen activator receptor (suPAR) is associated with inflammation and may predict lipodystrophy and dysmetabolism in human immunodeficiency virus (HIV)-infected individuals on antiretroviral therapy.
Van Rooyen, Johannes M., Schutte, Rudolph, Fourie, Carla M.T., Schutte, Aletta E., Kruger, Annamarie   +4 more
core   +2 more sources

Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in psoriasis patients and correlation with disease severity [PDF]

, 2015
Objective: Psoriasis is a chronic, relapsing, inflammatory, hyper-proliferative skin disease. Plasma-soluble urokinase plasminogen activator receptor (suPAR) is released from the cell membrane-bound plasminogen activator and is a new biomarker of ...
Akyuret, Fikret, Kesli, Recep, Akyürek, Fatma Tunçez, Akyürek, Fikret, Kurtipek, Gülcan Saylam, Terzi, Yüksel   +5 more
core   +1 more source

Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study

ESC Heart Failure
Aims Inflammation is postulated to be a key pathogenic mechanism in heart failure with preserved ejection fraction (HFpEF). Soluble urokinase plasminogen activator receptor (suPAR), a regulator of innate immune activity, is associated with incident heart
Christina G. Hutten, Annika Tekumulla, Anis Ismail, Alexi Vasbinder, Theresa Farhat, Pennelope Kunkle, Sascha N. Goonewardena, Ahmed Abdel‐Latif, Bertram Pitt, Salim S. Hayek   +9 more
doaj   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictor of Incident Atrial Fibrillation

, 2018
Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of chronic low-grade inflammation and a potent predictor of cardiovascular events.
Andersen, Ove, Rasmussen, Line Jee Hartmann, Friberg, Jens, Westin, Oscar, Buch, Eric, Olsen, Jesper Eugen-, Oscar Westin   +6 more
core   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

suPAR in CKD [PDF]

Nature Reviews Nephrology, 2015
openaire   +1 more source

SuPAR and Chronic Kidney Disease: Identifying Biomarkers for Disease Progression

, 2016
SuPAR (soluble urokinase-type plasminogen activator receptor) has been shown to be a promising biomarker in its ability to predict the development of chronic kidney disease in adults years earlier than traditional risk factors.
Weidemann, Darcy, Smith, Michael
core   +1 more source

Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD

Jornal Brasileiro de Pneumologia
Objective: To evaluate the value of soluble urokinase-type plasminogen activator receptor (suPAR) in the diagnosis of acute exacerbation of COPD (AECOPD) and in monitoring treatment response, analyzing the relationship between suPAR and fibrinogen in ...
Gehan Hassan AboEl-Magd, Maaly Mohamed Mabrouk   +1 more
doaj   +1 more source

Abstract 16154: Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Presence and Severity of Coronary Disease and is an Independent Predictor of Adverse Cardiovascular Outcomes

, 2012
Introduction: Soluble urokinase plasminogen activator receptor (suPAR) is an emerging inflammatory and immune biomarker. Recent studies have demonstrated a positive association of suPAR with incide..
Al Kassem, Hatem, Ghasemzadeh, Nima, Bhatia, Neal K., Le, Ngoc-Anh, Manocha, Pankaj, Thorball, Christian W., Hammadah, Muhammad, Wilmot, Kobina, Lerakis, Stamatios, Kabbany, Mohammad Tarek, Khayata, Mohamed, Yendamuri, Revanth, Quyyumi, Arshed A., Patel, Riyaz S., Veledar, Emir, Alradawi, Suliman, Halista, Michael M, Tahhan, Ayman Samman, Sperling, Laurence S., Eapen, Danny J., Asfari, Mohammad M, Pielak, Tomasz   +21 more
core   +1 more source